Eiger BioPharmaceuticals, Inc. Quarterly Return On Assets in % from Q3 2014 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Eiger BioPharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2014 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Return On Assets for the quarter ending December 31, 2023 was -113 %, a 69.1% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2023 was -113 %, a 69.1% decline from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2022 was -66.6 %, a 194% decline from 2021.
  • Eiger BioPharmaceuticals, Inc. annual Return On Assets for 2021 was -22.7 %, a 58.6% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 -113 -46.1 -69.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -99.8 -36.1 -56.8% Jul 1, 2023 Sep 30, 2023
Q2 2023 -87.9 -27.3 -45% Apr 1, 2023 Jun 30, 2023
Q1 2023 -73.6 -14.1 -23.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -66.6 -44 -194% Oct 1, 2022 Dec 31, 2022
Q3 2022 -63.6 -43.5 -217% Jul 1, 2022 Sep 30, 2022
Q2 2022 -60.7 -44.8 -283% Apr 1, 2022 Jun 30, 2022
Q1 2022 -59.5 -44.9 -307% Jan 1, 2022 Mar 31, 2022
Q4 2021 -22.7 +32 +58.6% Oct 1, 2021 Dec 31, 2021
Q3 2021 -20.1 +37.7 +65.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -15.8 +47.6 +75% Apr 1, 2021 Jun 30, 2021
Q1 2021 -14.6 +46.6 +76.1% Jan 1, 2021 Mar 31, 2021
Q4 2020 -54.7 +7.6 +12.2% Oct 1, 2020 Dec 31, 2020
Q3 2020 -57.8 +4.52 +7.26% Jul 1, 2020 Sep 30, 2020
Q2 2020 -63.5 +5.63 +8.15% Apr 1, 2020 Jun 30, 2020
Q1 2020 -61.2 +10.6 +14.8% Jan 1, 2020 Mar 31, 2020
Q4 2019 -62.3 +12.7 +17% Oct 1, 2019 Dec 31, 2019
Q3 2019 -62.3 +22.9 +26.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 -69.1 +14.5 +17.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -71.8 +33.6 +31.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -75 +26.4 +26.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -85.1 +10.6 +11.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -83.6 +5.29 +5.95% Apr 1, 2018 Jun 30, 2018
Q1 2018 -105 -15 -16.5% Jan 1, 2018 Mar 31, 2018
Q4 2017 -101 -18.4 -22.1% Oct 1, 2017 Dec 31, 2017
Q3 2017 -95.7 -40 -71.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -88.9 -39.2 -78.8% Apr 1, 2017 Jun 30, 2017
Q1 2017 -90.5 -36.7 -68.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -83 -52.9 -176% Oct 1, 2016 Dec 31, 2016
Q3 2016 -55.7 -49.4 -779% Jul 1, 2016 Sep 30, 2016
Q2 2016 -49.7 -41.6 -512% Apr 1, 2016 Jun 30, 2016
Q1 2016 -53.8 -62.4 -720% Jan 1, 2016 Mar 31, 2016
Q4 2015 -30.1 -27.2 -936% Oct 1, 2015 Dec 31, 2015
Q3 2015 -6.34 +10.5 +62.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -8.13 Apr 1, 2015 Jun 30, 2015
Q1 2015 8.68 Jan 1, 2015 Mar 31, 2015
Q4 2014 -2.91 Oct 1, 2014 Dec 31, 2014
Q3 2014 -16.9 Jul 1, 2014 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.